Svenska

Svenska

News
News
- Upcoming events
- Subscribe
About us
About us
Research & development
Research & development
Governance
Governance
Investors
Investors
Media
Media
Subscribe
Contact
Contact
- Office
- Investors
- Media

Search for:

Extraordinary General Meeting 2025

July 2, 2025

An extraordinary general meeting was held on Wednesday 2 July 2025.

Documents

Minutes from the Extraordinary General Meeting 2025 Swedish July 2, 2025
The extraordinary general meeting of AlzeCure Pharma AB approved the decision on the new issue of shares English July 2, 2025
NOTICE TO EXTRAORDINARY GENERAL MEETING 2025 IN ALZECURE PHARMA AB English June 16, 2025
Proxy form – Extraordinary General Meeting 2025 English
The board of directors’ report pursuant to chapter 13 section of the Swedish Companies Act Swedish/English
Revisorns yttrande enligt 13 kap. 6 § ABL Swedish

Governance

News

Upcoming events
Subscribe

About us

AlzeCure Pharma in brief
Mission, Vision & Strategy
A word from the CEO
Organization
Career
History

Research & development

Project portfolio
NeuroRestore
Alzstatin
Alzheimer’s disease
Depression
Painless
Pain
Small molecules
Publications
The patients story

Governance

Corporate Governance Reports
General meeting
Nomination Committee
Board of directors
Management team
Remuneration
Auditors
Articles of association

Investors

Rights issue 2025
Capital Markets Day 2023
AlzeCure Pharma on First North Premier Growth Market
Prospectuses
The share
Financial reports
Financial calendar
Presentations and Interviews
Press releases
Subscribe
Contact

Media

Press releases
Presentations and Interviews
Video gallery
Image bank
Financial calendar
Subscribe
Contact

Contact

Office
Investors
Media

AlzeCure Pharma AB, Hälsovägen 7, SE-141 57 Huddinge, Sweden. Registration number: 559094-8302.

Follow us on LinkedIn

About cookies
Privacy policy for Alzecure Pharma